Papers/PMID:26714044
Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.
Atherosclerosis2016The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
chondroitin sulfate — decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“DIO obese mice treated with CS showed lower serum levels of the mediators of the inflammatory response IL-1β and TNF-α than animals receiving vehicle.”
Quoted verbatim from Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.. - Study
- animal · not in humans
- Duration
- 6 days
- Dose
- 1 g/kg/day
- Population
- Male diet-induced obese mice on a high-fat diet, CS 1 g/kg/day versus saline vehicle for 6 days
Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.2016PMID:26714044Permalink